KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Capital Employed: 2018-2024

Historic Return on Capital Employed for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Dec 2024 value amounting to 0.11%.

  • Amneal Pharmaceuticals' Return on Capital Employed rose 6.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 6.00%. This contributed to the annual value of 0.11% for FY2024, which is 3.00% up from last year.
  • Amneal Pharmaceuticals' Return on Capital Employed amounted to 0.11% in FY2024, which was up 44.36% from 0.07% recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Capital Employed registered a high of 0.11% during FY2024, and its lowest value of -0.03% during FY2022.
  • Its 3-year average for Return on Capital Employed is 0.05%, with a median of 0.07% in 2023.
  • In the last 5 years, Amneal Pharmaceuticals' Return on Capital Employed grew by 10bps in 2020 and then declined by 8bps in 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' Return on Capital Employed (Yearly) stood at 0.03% in 2020, then increased by 2bps to 0.05% in 2021, then decreased by 8bps to -0.03% in 2022, then grew by 10bps to 0.07% in 2023, then increased by 3bps to 0.11% in 2024.